Welcome to LookChem.com Sign In|Join Free
  • or
Ethyl 1-({[(4-methylphenyl)sulfonyl]oxy}methyl)cyclopropanecarboxylate is a complex organic chemical compound with the molecular formula C14H18O5S. It is a colorless liquid with a density of 1.22 g/cm3 and a melting point of -34°C. ethyl 1-({[(4-methylphenyl)sulfonyl]oxy}methyl)cyclopropanecarboxylate is characterized by the presence of a cyclopropane ring, a sulfonyl group, and an ester functional group. It is synthesized through a series of chemical reactions involving the substitution of a hydroxyl group with an ethyl group and the formation of a sulfonyl ether linkage. Ethyl 1-({[(4-methylphenyl)sulfonyl]oxy}methyl)cyclopropanecarboxylate is primarily used as an intermediate in the synthesis of pharmaceuticals and other organic compounds, due to its unique structure and reactivity.

4845-11-8

Post Buying Request

4845-11-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4845-11-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 4845-11-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,8,4 and 5 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 4845-11:
(6*4)+(5*8)+(4*4)+(3*5)+(2*1)+(1*1)=98
98 % 10 = 8
So 4845-11-8 is a valid CAS Registry Number.

4845-11-8Downstream Products

4845-11-8Relevant academic research and scientific papers

HIGHLY ACTIVE CSF1R INHIBITOR COMPOUND

-

Paragraph 0113; 0136-0137, (2020/12/10)

ABSTRACT The present invention relates to a CSF1R inhibitor, and in particular to a highly active CSF1R inhibitor compound having the structure of formula (I). Said compound of the present invention has high inhibitory activity on CSF1R.

2- PYRIDONE COMPOUND

-

Paragraph 0312; 0313, (2016/10/08)

PROBLEM TO BE SOLVED: To provide a compound that has excellent glucokinase (GK) activating action and is useful as a pharmaceutical. SOLUTION: The present invention provides a 2-pyridone compound represented by formula [1], and a tautomer or stereoisomer of the compound, or their pharmacologically acceptable salts, or their solvates (where R1 is RA-ZA-; RA is any of a carboxy group, a sulfo group or formula [5]). COPYRIGHT: (C)2016,JPOandINPIT

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4845-11-8